Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment
- PMID: 9721884
Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment
Abstract
Up-regulation of CD44 variant isoforms has been linked to the progression of epithelial tumors and the metastatic phenotype. Here we report a functional role for CD44 variant isoforms in colorectal cancer metastasis. An antisense mRNA approach was used to down-regulate CD44 variant isoforms containing CD44 variant 6 (v6) in the metastatic colorectal tumor cell line HT29. Cell lines stably expressing antisense CD44 exon 10 (v6) showed reduced expression of alternatively spliced CD44 variant isoforms but no significant change in expression of CD44 core protein, as judged by immunohistochemical analysis using CD44 domain-specific monoclonal antibodies. Expression of antisense exon 10 (v6) had no effect on HT29 tumor cell proliferation in vitro or the ability of the cells to bind immobilized hyaluronan, but it resulted in a reduced capacity to form liver metastases in nude mice following intrasplenic injection. Metastases were not detected in nude mice inoculated with antisense CD44 exon 10 (v6)-expressing cell lines after 4 months, against a background of a 30% metastasis rate in the control HT29 parental and vector alone transfected lines. Furthermore, whereas 82% of mice intrasplenically injected with control HT29 parental and vector alone cell lines developed tumors in incisional wound sites, none of the mice injected with antisense exon 10 expressing HT29 cells developed similar tumors. This is the first demonstration that antisense RNA can be used to selectively inhibit expression of specific domains of a molecule generated through alternative mRNA splicing while allowing expression of core domains to remain unaffected. Furthermore, these results provide direct evidence for a functional role of CD44 variant isoforms in the metastasis of human colorectal tumor cells and may suggest a critical role for CD44 variants in promoting cell growth specifically in the cytokine/growth factor-enriched environment of a wound site.
Similar articles
-
Expression of CD44 standard and isoforms in human breast cancer xenografts and shedding of soluble forms into serum of nude mice.Anticancer Res. 1997 Sep-Oct;17(5A):3633-45. Anticancer Res. 1997. PMID: 9413216
-
Alternative splicing of CD44 pre-mRNA in human colorectal tumors.Biochem Biophys Res Commun. 1994 Apr 29;200(2):1015-22. doi: 10.1006/bbrc.1994.1551. Biochem Biophys Res Commun. 1994. PMID: 7513991
-
Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.Clin Cancer Res. 1996 Sep;2(9):1607-18. Clin Cancer Res. 1996. PMID: 9816340
-
CD44 splice variants: expression during lymphocyte activation and tumor progression.Behring Inst Mitt. 1993 Aug;(92):273-7. Behring Inst Mitt. 1993. PMID: 7504454 Review.
-
Analysis of molecular functions of the tumor metastasis promoting surface molecule CD44v4-v7 using transgenic mice.Princess Takamatsu Symp. 1994;24:142-51. Princess Takamatsu Symp. 1994. PMID: 8983071 Review.
Cited by
-
Demonstration of a melanoma-specific CD44 alternative splicing pattern that remains qualitatively stable, but shows quantitative changes during tumour progression.PLoS One. 2013;8(1):e53883. doi: 10.1371/journal.pone.0053883. Epub 2013 Jan 14. PLoS One. 2013. PMID: 23342032 Free PMC article.
-
Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis.Virchows Arch. 2004 Nov;445(5):456-64. doi: 10.1007/s00428-004-1095-0. Epub 2004 Sep 16. Virchows Arch. 2004. PMID: 15375658
-
Characteristics of CD44 alternative splice pattern in the course of human colorectal adenocarcinoma progression.Mol Cancer. 2012 Nov 14;11:83. doi: 10.1186/1476-4598-11-83. Mol Cancer. 2012. PMID: 23151220 Free PMC article.
-
Progastrin overexpression imparts tumorigenic/metastatic potential to embryonic epithelial cells: phenotypic differences between transformed and nontransformed stem cells.Int J Cancer. 2012 Oct 1;131(7):E1088-99. doi: 10.1002/ijc.27615. Epub 2012 May 17. Int J Cancer. 2012. PMID: 22532325 Free PMC article.
-
Selectins and selectin ligands in extravasation of cancer cells and organ selectivity of metastasis.Clin Exp Metastasis. 2008;25(4):335-44. doi: 10.1007/s10585-007-9096-4. Epub 2007 Sep 21. Clin Exp Metastasis. 2008. PMID: 17891461 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous